All In Biotech

Drug Trial Radar · NCT00042848

Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy

Last checked: Nov 20, 2026Latest source record: Oct 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 837 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

837

Planned (sponsor's estimate)

Start

Aug 2002

Primary completion

Apr 2007

Study completion Oct 2007

Sponsor

Lead sponsor
Gary MorrowAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Jan 27, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
Double
Primary purpose
Supportive care
Who can join
All sexes, from 18 years, up to 120 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known. PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.

Conditions

  • Fatigue
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

  • modafinilDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy to reduce fatigue during chemotherapy as assessed by the Brief Fatigue Inventory at course 4

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • MBCCOP - Gulf Coast

    Mobile, Alabama

  • CCOP - Western Regional, Arizona

    Phoenix, Arizona

  • CCOP - Santa Rosa Memorial Hospital

    Santa Rosa, California

  • Medical Center of Aurora - South Campus

    Aurora, Colorado

  • Boulder Community Hospital

    Boulder, Colorado

  • Penrose Cancer Center at Penrose Hospital

    Colorado Springs, Colorado

  • Porter Adventist Hospital

    Denver, Colorado

  • St. Joseph Hospital

    Denver, Colorado

  • Presbyterian - St. Luke's Medical Center

    Denver, Colorado

  • Rocky Mountain Cancer Centers - Denver Rose

    Denver, Colorado

  • CCOP - Colorado Cancer Research Program

    Denver, Colorado

  • Swedish Medical Center

    Englewood, Colorado

  • Sky Ridge Medical Center

    Lone Tree, Colorado

  • Rocky Mountain Cancer Centers - Longmont

    Longmont, Colorado

  • St. Mary-Corwin Regional Medical Center

    Pueblo, Colorado

  • Rocky Mountain Cancer Centers - Thornton

    Thornton, Colorado

  • MBCCOP - Hawaii

    Honolulu, Hawaii

  • MBCCOP - University of Illinois at Chicago

    Chicago, Illinois

  • CCOP - Central Illinois

    Decatur, Illinois

  • CCOP - Evanston

    Evanston, Illinois

  • CCOP - Wichita

    Wichita, Kansas

  • CCOP - Kalamazoo

    Kalamazoo, Michigan

  • CCOP - Metro-Minnesota

    Saint Louis Park, Minnesota

  • CCOP - Kansas City

    Kansas City, Missouri

  • CCOP - Nevada Cancer Research Foundation

    Las Vegas, Nevada

  • CCOP - Hematology-Oncology Associates of Central New York

    East Syracuse, New York

  • CCOP - North Shore University Hospital

    Manhasset, New York

  • CCOP - Southeast Cancer Control Consortium

    Goldsboro, North Carolina

  • CCOP - Columbus

    Columbus, Ohio

  • CCOP - Dayton

    Dayton, Ohio

  • CCOP - Columbia River Oncology Program

    Portland, Oregon

  • CCOP - Greenville

    Greenville, South Carolina

  • CCOP - Virginia Mason Research Center

    Seattle, Washington

  • CCOP - Northwest

    Tacoma, Washington

  • CCOP - Marshfield Clinic Research Foundation

    Marshfield, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.